ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Shennon Biotechnologies has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Shennon Biotechnologies's investors include Foundation Capital, DCVC, AV8 Ventures, Jasper Lau, Mei Z..
Shennon Biotechnologies is headquartered in San Francisco, United States.
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Shennon Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shennon Biotechnologies — Funding & Investors." VCBacked, March 13, 2023, https://www.vcbacked.co/company/shennon-biotechnologies. Accessed July 27, 2026.
VCBacked. (2023). Shennon Biotechnologies — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/shennon-biotechnologies
{{cite web |title=Shennon Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/shennon-biotechnologies |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated